Cardinal Health Inc (CAH)

70.83
0.10 0.14
NYSE : Services
Prev Close 70.93
Open 71.19
Day Low/High 70.74 / 71.68
52 Wk Low/High 62.70 / 91.22
Volume 2.36M
Avg Volume 3.11M
Exchange NYSE
Shares Outstanding 320.06M
Market Cap 22.73B
EPS 4.40
P/E Ratio 17.19
Div & Yield 1.80 (2.50%)

Latest News

Stocks Lose Highs as Crude Tumbles to One-Month Low

Stocks Lose Highs as Crude Tumbles to One-Month Low

U.S. stocks hold onto slight gains by midday Monday an earnings-driven jump in utilities offsets a decline in energy.

Cramer: Nike Is a Victim of Price Wars; There Will Be Others

Cramer: Nike Is a Victim of Price Wars; There Will Be Others

Look out below when it comes to margins, as the price wars extend to sneakers, drugs and others.

Jim Cramer -- Health Care Could Be Susceptible to More Declines

Jim Cramer -- Health Care Could Be Susceptible to More Declines

Jim Cramer says health care stocks could see a temporary relief rally, but may be susceptible to further downside.

Stocks Up Slightly as GE Headlines Deal News, Crude Falls

Stocks Up Slightly as GE Headlines Deal News, Crude Falls

U.S. stocks rise slightly on Monday as General Electric headlines a busy morning for deal news.

Cardinal Health (CAH) Stock Gains on Q1 Beat

Cardinal Health (CAH) Stock Gains on Q1 Beat

Cardinal Health (CAH) reported fiscal 2017 first quarter results on Monday that were better than expected.

Cramer: Investors Look at Merck, Wondering Why They Did Not Buy Qualcomm

Cramer: Investors Look at Merck, Wondering Why They Did Not Buy Qualcomm

In a "take no pain, take no prisoners" market, health care stocks languish.

Jim Cramer's Top Takeaways: Amerisource Bergen, Avon And More

Jim Cramer's Top Takeaways: Amerisource Bergen, Avon And More

Drug wholesalers are battling it out, while Avon is looking better, says Jim Cramer.

Jim Cramer's 'Mad Money' Recap: How Powerful Are GE, Royal Dutch Shell and Occidental?

Jim Cramer's 'Mad Money' Recap: How Powerful Are GE, Royal Dutch Shell and Occidental?

Cramer previews important earnings reports scheduled for the coming week.

McKesson Takes a Hit on Earnings, Drags Cardinal and Amerisource Bergan Down With It

McKesson Takes a Hit on Earnings, Drags Cardinal and Amerisource Bergan Down With It

McKesson Corp. (MCK) hit a 52-week low Friday, falling 23% Friday, hitting $114 per share before bouncing back to $124.57 before market's close.

Cardinal Health (CAH) Stock Tumbles on Pricing Concerns

Cardinal Health (CAH) Stock Tumbles on Pricing Concerns

Cardinal Health (CAH) is under pressure after its competitor McKesson (MCK) slashed its profit outlook for fiscal 2017.

Jim Cramer Explains Why Health Care Stocks are Getting Slammed on Wall Street Today

Jim Cramer Explains Why Health Care Stocks are Getting Slammed on Wall Street Today

McKesson's disappointing earnings report ignited a selloff in health care stocks, and Jim Cramer says investors are questioning the sector's future.

Jim Cramer: Healthcare Stocks in Crosshairs

Jim Cramer: Healthcare Stocks in Crosshairs

The pricing structure of the healthcare and drug distribution industry has been wrecked and Wall Street is taking down those stocks as a result, says Jim Cramer.

Analysts' Actions -- AK Steel, McKesson, Qualcomm, Twitter and More

Analysts' Actions -- AK Steel, McKesson, Qualcomm, Twitter and More

Here are Friday's top research calls, including upgrades for AK Steel, ServiceNow, Qualcomm and Twitter, and downgrades for McKesson, Mead Johnson and GNC.

Cardinal Health Becomes #132 Most Shorted S&P 500 Component, Replacing Urban Outfitters

Cardinal Health Becomes #132 Most Shorted S&P 500 Component, Replacing Urban Outfitters

The most recent short interest data has been released for the 10/14/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Cardinal Health Becomes #209 Most Shorted S&P 500 Component, Replacing Blackrock

Cardinal Health Becomes #209 Most Shorted S&P 500 Component, Replacing Blackrock

The most recent short interest data has been released for the 09/30/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

4 Blue-Chip Stocks With Attractive Dividends and Ugly Charts

4 Blue-Chip Stocks With Attractive Dividends and Ugly Charts

These stocks might sport safe dividend payouts, but their charts are too weak to buy.

Top 10 Dividend Stocks to Withstand October's Typical Volatility

Top 10 Dividend Stocks to Withstand October's Typical Volatility

Scoop up safe, growing dividends with these top dividend stocks for October.

Family Offices Start Taking the Look of Financial Sponsors

Family Offices Start Taking the Look of Financial Sponsors

Long the bastion of the fabulously rich, these firms are no longer letting others do their bidding and are instead directly investing in portfolio companies themselves.

Johnson & Johnson Sees Growth in Ophthalmology, Acquires Abbott Medical Optics

Johnson & Johnson Sees Growth in Ophthalmology, Acquires Abbott Medical Optics

The deal comes as Abbott works to complete two pending transactions worth nearly $40 billion combined and is the latest in the slew of ophthalmology deals.

On Cardinal Health, Keep an Eye on $75

On Cardinal Health, Keep an Eye on $75

Why this level on CAH is so important, and what you need to know about it.

Analysts' Actions -- Citigroup, Comerica, Novavax, PepsiCo and More

Analysts' Actions -- Citigroup, Comerica, Novavax, PepsiCo and More

Here are Friday's top research calls, including downgrades for Citigroup and Novavax, an upgrade Comerica and new coverage of PepsiCo.

Why It's Time to Buy This Year's Worst-Performing Dividend Aristocrat Stock

Why It's Time to Buy This Year's Worst-Performing Dividend Aristocrat Stock

The worst-performing Dividend Aristocrat is down 14% so far this year, but temporary underperformance may lead to long-term outperformance with this high-quality stock.

Navidea Biopharmaceuticals Enters Into Letter Of Intent With Cardinal Health For The Sale Of Lymphoseek® In North America

Navidea Biopharmaceuticals Enters Into Letter Of Intent With Cardinal Health For The Sale Of Lymphoseek® In North America

Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB) today announced that it has executed a Letter of Intent ("LOI") with Cardinal Health, Inc.

Cramer: The Answer to This Market: Part 1

Cramer: The Answer to This Market: Part 1

The leadership is quite stark.

Cardinal Health: The Best Dividend Aristocrat to Buy Today

Cardinal Health: The Best Dividend Aristocrat to Buy Today

Cardinal Health (CAH) offers a compelling dividend investment opportunity. Here's why.